id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0915-0004,FDA,FDA-2011-N-0915,"Agency Information Collection Activities; Proposed Collection;
Submission for Office of Management and Budget Review; Guidance for
Industry on Postmarketing Adverse Event Reporting for Nonprescription
Human Drug Products Marketed Without an Approved Application",Notice,30 Day Proposed Information Collection,2015-06-25T04:00:00Z,2015,6,2015-06-25T04:00:00Z,2015-07-28T03:59:59Z,2015-06-25T13:48:52Z,2015-15638,0,0,0900006481b54bc8
FDA-2011-N-0915-0003,FDA,FDA-2011-N-0915,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Guidance for Industry on Postmarketing Adverse
Event Reporting for Nonprescription Human Drug Products Marketed
Without an Approved Application",Notice,60 Day Proposed Information Collection,2015-01-23T05:00:00Z,2015,1,2015-01-23T05:00:00Z,2015-03-25T03:59:59Z,2015-03-24T02:04:49Z,2015-01111,0,0,09000064819db747